R.B. Naso

1.3k total citations
27 papers, 1.2k citations indexed

About

R.B. Naso is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, R.B. Naso has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 12 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in R.B. Naso's work include Virus-based gene therapy research (14 papers), HIV Research and Treatment (7 papers) and RNA Interference and Gene Delivery (4 papers). R.B. Naso is often cited by papers focused on Virus-based gene therapy research (14 papers), HIV Research and Treatment (7 papers) and RNA Interference and Gene Delivery (4 papers). R.B. Naso collaborates with scholars based in United States and France. R.B. Naso's co-authors include Ralph B. Arlinghaus, G A Jamjoom, W.L. Karshin, L.J. Arcement, Ali Fattom, Jawad Sarwar, A. Ortiz, C. Kennedy, Stephen A. Spector and J Rosen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

R.B. Naso

26 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.B. Naso United States 16 495 423 382 324 315 27 1.2k
D. van Zaane Netherlands 16 282 0.6× 254 0.6× 142 0.4× 189 0.6× 243 0.8× 19 1.1k
G. Appleyard United Kingdom 20 453 0.9× 450 1.1× 513 1.3× 379 1.2× 272 0.9× 41 1.7k
Janet S. Bootman United Kingdom 15 279 0.6× 132 0.3× 316 0.8× 309 1.0× 360 1.1× 22 1.2k
M Francotte United States 13 440 0.9× 161 0.4× 660 1.7× 481 1.5× 370 1.2× 20 1.4k
G A Jamjoom Saudi Arabia 11 237 0.5× 234 0.6× 191 0.5× 161 0.5× 120 0.4× 15 721
T. J. Wiktor United States 15 286 0.6× 310 0.7× 900 2.4× 232 0.7× 454 1.4× 25 1.4k
Gerald A. Beltz United States 16 513 1.0× 349 0.8× 269 0.7× 296 0.9× 322 1.0× 19 1.2k
C Pachl United States 18 304 0.6× 275 0.7× 414 1.1× 265 0.8× 302 1.0× 21 1.5k
Mitra C. Singhal United States 14 341 0.7× 121 0.3× 306 0.8× 342 1.1× 244 0.8× 20 1.1k
M. P. Kieny France 20 651 1.3× 426 1.0× 1.2k 3.1× 605 1.9× 514 1.6× 30 2.0k

Countries citing papers authored by R.B. Naso

Since Specialization
Citations

This map shows the geographic impact of R.B. Naso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.B. Naso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.B. Naso more than expected).

Fields of papers citing papers by R.B. Naso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.B. Naso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.B. Naso. The network helps show where R.B. Naso may publish in the future.

Co-authorship network of co-authors of R.B. Naso

This figure shows the co-authorship network connecting the top 25 collaborators of R.B. Naso. A scholar is included among the top collaborators of R.B. Naso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.B. Naso. R.B. Naso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krawczyński, K., Ali Fattom, David H. Culver, et al.. (2000). Experimental immune treatment of hepatitis C virus (HCV) infection:Passive anti-HCV (HCIg) transfer in chronically infected chimpanzees. Journal of Hepatology. 32. 37–37. 9 indexed citations
2.
Fattom, Ali, Jawad Sarwar, A. Ortiz, & R.B. Naso. (1996). A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infection and Immunity. 64(5). 1659–1665. 144 indexed citations
3.
4.
Hendricks, Michael, Robert J. LaPolla, J Rosen, et al.. (1990). Cloning of the amino terminal nucleotides of the antigen I/II of Streptococcus sobrinus and the immune responses to the corresponding synthetic peptides. Archives of Oral Biology. 35. S47–S52. 9 indexed citations
5.
Smith, R. Stephen, R.B. Naso, J Rosen, et al.. (1987). Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection. Journal of Clinical Microbiology. 25(8). 1498–1504. 57 indexed citations
6.
Naso, R.B., et al.. (1984). Cytoskeleton-associated Pr65 and assembly of retrovirus temperature-sensitive mutants in chronically infected cells. Virology. 134(2). 389–397. 20 indexed citations
7.
Naso, R.B., L.H. Stanker, John J. Kopchick, et al.. (1983). Further studies on the glycosylated gag gene products of Rauscher murine leukemia virus: identification of an N-terminal 45,000-dalton cleavage product. Journal of Virology. 45(3). 1200–1206. 7 indexed citations
8.
Naso, R.B., et al.. (1983). Cytoskeleton-associated Pr65 and retrovirus assembly. Virology. 130(2). 415–426. 18 indexed citations
9.
Fuqua, Suzanne A.W. & R.B. Naso. (1982). A Comparison of the Intracellular Precursor Polyproteins of Simian Sarcoma-associated Virus [SiSV(SiAV)] and Three Human Virus Isolates: HL23V, HEL12V and A1476V. Journal of General Virology. 62(1). 49–63. 2 indexed citations
10.
Shewach, Donna S., R.B. Naso, & William Plunkett. (1981). Relationship between ARA-ATP concentration, DNA synthetic capacity (DSC) and viability in CHO cells. Proceedings of the American Association for Cancer Research. 22. 1 indexed citations
11.
Naso, R.B., et al.. (1979). Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. Journal of Virology. 32(1). 187–198. 42 indexed citations
12.
Jamjoom, G A, R.B. Naso, & Ralph B. Arlinghaus. (1977). Further characterization of intracellular precursor polyproteins of rauscher leukemia virus. Virology. 78(1). 11–34. 146 indexed citations
13.
Karshin, W.L., L.J. Arcement, R.B. Naso, & Ralph B. Arlinghaus. (1977). Common Precursor for Rauscher Leukemia Virus gp69/71, p15(E), and p12(E). Journal of Virology. 23(3). 787–798. 94 indexed citations
14.
Naso, R.B., et al.. (1976). Variations in rat liver chromatin composition during growth and the heterotic response. Biochemical Genetics. 14(3-4). 281–292. 3 indexed citations
15.
Arcement, L.J., W.L. Karshin, R.B. Naso, G A Jamjoom, & Ralph B. Arlinghaus. (1976). Biosynthesis of Rauscher leukemia viral proteins: Presence of p30 and envelope p15 sequences in precursor polypeptides. Virology. 69(2). 763–774. 126 indexed citations
16.
Jamjoom, G A, R.B. Naso, & Ralph B. Arlinghaus. (1976). Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. Journal of Virology. 19(3). 1054–1072. 44 indexed citations
17.
Naso, R.B., L.J. Arcement, W.L. Karshin, G A Jamjoom, & Ralph B. Arlinghaus. (1976). A fucose-deficient glycoprotein precursor to Rauscher leukemia virus gp69/71.. Proceedings of the National Academy of Sciences. 73(7). 2326–2330. 86 indexed citations
18.
Jamjoom, G A, W.L. Karshin, R.B. Naso, L.J. Arcement, & Ralph B. Arlinghaus. (1975). Proteins of Rauscher murine leukemia virus: Resolution of a 70,000-dalton, nonglycosylated polypeptide containing p30 peptide sequences. Virology. 68(1). 135–145. 48 indexed citations
19.
Naso, R.B., et al.. (1972). Purification of Large Amounts of Murine Ribonucleic Acid Tumor Viruses Produced in Roller Bottle Cultures. Applied Microbiology. 24(3). 488–494. 63 indexed citations
20.
Naso, R.B., et al.. (1972). Purification of Large Amounts of Murine Ribonucleic Acid Tumor Viruses Produced in Roller Bottle Cultures. Applied Microbiology. 24(3). 488–494. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026